Sciencast Management’s Royalty Pharma RPRX Stock Holding History

Sciencast Management’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.69M	Sell	30,073 -13,914	-32%	-$724K	0.35%	121
2026 Q1	$2.11M	Sell	43,987 -33,254	-43%	-$1.46M	0.27%	145
2025 Q4	$2.98M	Buy	+77,241	New	+$2.95M	0.41%	107
2025 Q1	–	Sell	-39,132	Closed	-$998K	–	347
2024 Q4	$998K	Buy	+39,132	New	+$1.04M	0.27%	136
2024 Q1	–	Sell	-29,080	Closed	-$817K	–	312
2023 Q4	$817K	Buy	+29,080	New	+$799K	0.45%	95
2023 Q2	–	Sell	-21,688	Closed	-$751K	–	306
2023 Q1	$751K	Buy	+21,688	New	+$804K	1%	23
2021 Q3	–	Sell	-21,199	Closed	-$884K	–	575
2021 Q2	$884K	Buy	21,199 +14,099	+199%	+$600K	0.19%	168
2021 Q1	$297K	Buy	+7,100	New	+$337K	0.06%	394

Other funds holding RPRX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sciencast Management's RPRX Position: Q2 2026 in Review

Sciencast Management reduced its Royalty Pharma (RPRX) stake by 32% in Q2 2026, selling an estimated $724K and leaving 30,073 shares worth $1.69M. The position accounts for 0.35% of the portfolio, ranked #121.

Sciencast Management first reported a position in RPRX in Q1 2021 and has held it in 8 quarters since. The position peaked at $2.98M in Q4 2025. 643 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

Sciencast Management held 30,073 shares of Royalty Pharma worth $1.69M as of Q2 2026.
Sciencast Management sold 13,914 Royalty Pharma shares in Q2 2026, an estimated $724K.
Royalty Pharma made up 0.35% of Sciencast Management's portfolio in Q2 2026, its #121 holding.
Sciencast Management first reported a position in Royalty Pharma in Q1 2021 and has held it in 8 quarters since.
Sciencast Management's Royalty Pharma position peaked at $2.98M in Q4 2025.
643 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Sciencast Management's 13F filing for Q2 2026, filed 28 Jul 2026.